Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed

Permanent URI for this communityhttps://hdl.handle.net/20.500.14719/1741

Browse

Search Results

Now showing 1 - 10 of 15
  • Publication
    A Review of Methods for the Preservation of Laryngeal Nerves During Thyroidectomy
    (KARE PUBL, 2018) Uludag, Mehmet; Tanal, Mert; Isgor, Adnan; University of Health Sciences Turkey; Bahcesehir University; Memorial Healthcare Group
  • Publication
    Standards and Definitions in Neck Dissections of Differentiated Thyroid Cancer
    (YERKURE TANITIM YAYINCILIK HIZMETLERI AS, 2018) Uludag, Mehmet; Tanal, Mert; Isgor, Adnan; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; Bahcesehir University; Memorial Healthcare Group
  • Publication
    Lupus Miliaris Disseminatus Faciei: A Case Report and Brief Literature Review
    (YERKURE TANITIM YAYINCILIK HIZMETLERI AS, 2018) Cerman, Asli Aksu; Karabay, Ezgi Aktas; Yalcin, Ozben; Altunay, Ilknur Kivanc; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; Bahcesehir University
  • Publication
    Can Active Surveillance be an Alternative to Surgery in Papillary Thyroid Microcarcinoma?: The Current Situation Worldwide
    (KARE PUBL, 2018) Aygun, Nurcihan; Isgor, Adnan; Uludag, Mehmet; University of Health Sciences Turkey; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; Bahcesehir University; Memorial Healthcare Group
    Papillary thyroid carcinoma is the most common endocrine malignancy. Papillary thyroid microcarcinomas (PTMCs) are tumors with a size of <= 1 cm. The biological behavior of these tumors differs due to the presence of their aggressive features. The prognosis of PTMCs with high-risk features, such as clinical node metastasis, distant metastasis, and significant extrathyroidal extension to the tracheal or recurrent laryngeal nerve invasion, is poor, even if a sufficient immediate surgery is performed at diagnosis. However, PTMCs without these aggressive features are low-risk tumors because of their indolent and slow growth behaviors. The increase in thyroid cancer incidence is mostly a result of overdiagnosis of small low-risk PTMCs with indolent clinical course. Despite the sudden increase in thyroid cancer incidence worldwide, cancer mortality did not increase. Although the traditional treatment strategy for PTMC is immediate surgery at diagnosis, because of the rather low disease-specific mortality rate, low recurrence rate, and potential risk for postoperative complications, active surveillance has been proposed recently as an alternative option for PTMCs without invasion, metastasis, or cytological or molecular characteristics. The recent data support that active surveillance of low-risk PTMC should be the initial treatment modality, because only a small percentage of low-risk PTMCs show signs of progression, and delayed surgery has not caused significant recurrence. However, recent management guidelines are shifting toward more conservative treatments, such as active surveillance. Although there is an increase in the number of studies related to active surveillance, prospective studies have been mostly from academic referral centers in Japan. The world still needs class 1 evidence extended prospective studies originating from different geographic regions. Active surveillance may be a good alternative to immediate surgery for appropriately selected patients with PTMC.
  • Publication
    The Developing Story of Predictive Biomarkers in Colorectal Cancer
    (MDPI, 2019) Boussios, Stergios; Ozturk, Mehmet Akif; Moschetta, Michele; Karathanasi, Afroditi; Zakynthinakis-Kyriakou, Nikolaos; Katsanos, Konstantinos H.; Christodoulou, Dimitrios K.; Pavlidis, Nicholas; Bahcesehir University; University of Ioannina; University Hospital Ioannina; University of Ioannina
    Colorectal cancer (CRC) is the third most common malignancy worldwide. Surgery remains the most important treatment for non-metastatic CRC, and the administration of adjuvant chemotherapy depends mainly on the disease stage, which is still the strongest prognostic factor. A refined understanding of the genomics of CRC has recently been achieved thanks to the widespread use of next generation sequencing with potential future therapeutic implications. Microsatellite instability (MSI) has been suggested as a predictive marker for response to anti-programmed-cell-death protein 1 (PD-1) therapy in solid tumors, including CRC. It should be noted that not all cancers with MSI phenotype respond to anti-PD-1 immunotherapy, highlighting the urgent need for even better predictive biomarkers. Mitogen-Activated Protein Kinase (MAPK) pathway genes KRAS, NRAS, and BRAF represent important molecular targets and could serve as independent prognostic biomarkers in CRC, and identify those who potentially benefit from anti-epidermal growth factor receptor (EGFR) treatment. Emerging evidence has attributed a significant role to inflammatory markers including blood cell ratios in the prognosis and survival of CRC patients, these biomarkers can be easily assessed in routine blood exams and be used to identify high-risk patients or those more likely to benefit from chemotherapy, targeted therapies and potentially immunotherapy. Analysis of cell-free DNA (cfDNA), circulating tumor cells (CTC) and/or micro RNAs (miRNAs) could provide useful information for the early diagnosis of CRC, the identification of minimal residual disease and, the evaluation of the risk of recurrence in early CRC patients. Even the selection of patients suitable for the new targeted therapy is becoming possible with the use of predictive miRNA biomarkers. Finally, the development of treatment resistance with the emergence of chemo-resistance clones after treatment remains the most important challenge in the clinical practice. In this context it is crucial to identify potential biomarkers and therapeutic targets which could lead to development of new and more effective treatments.
  • Publication
    Rewarding Conversation Between Oocyte and Cumulus Cells Directs the Process of Folliculogenesis
    (GAZI UNIV, FAC MED, 2019) Dayanir, Duygu; Ruso, Halil; Kalem, Ziya; Gurgan, Timur; Ozogul, Candan; Gazi University; Bahcesehir University
    The process of folliculogenesis needs a balanced environment to create a mature oocyte that is expected to have characteristics in order to form the ability of a healthy fertilisation. Previous studies have been focused on endocrine effects of hypothalamic-pituitary system on ovarian functions. Influences of this system have been studied for many years. Besides of extraovarian factors, recent studies have focused on intraovarian factors which forms the relationship between oocyte and cumulus cells. It has been shown that even the maturity of antral follicule and oocyte has been effected from this communication. These factors which takes part at process of folliculogenesis, were shown to be efficient even at the success of assisted reproductive technologies. We studied general lines of this conversation based on main research articles that continue to be relevant at this topic.
  • Publication
    Main Surgical Principles and Methods in Surgical Treatment of Primary Hyperparathyroidism
    (KARE PUBL, 2019) Uludag, Mehmet; Aygun, Nurcihan; Isgor, Adnan; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; University of Health Sciences Turkey; Bahcesehir University
    The only curative treatment for primary hyperparathyroidism (pHPT) is surgery. The most important factors that increase the success rate of a parathyroidectomy are the establishment of the correct diagnosis and the surgeon's good knowledge of anatomy and embryology. The lower parathyroid glands develop from the dorsal portion of the third pharyngeal pouch, and the upper parathyroid glands from the fourth pharyngeal pouch. Humans typically have 4 parathyroid glands, however, more than 4 and fewer than 4 have been observed. Typically, the upper parathyroid glands are located in the cricothyroid junction area on the posterolateral portion of the middle and upper third of the thyroid, while the lower parathyroids are located in an area 1 cm in diameter located posterior, lateral, or anterolateral to the lower thyroid pole. Ectopic locations of parathyroid glands outside the normal anatomical regions due to the abnormal migration during embryological development or acquired ectopy due to migration of enlarged parathyroids are not uncommon. There are various surgical techniques to treat HPT, however, 2 main surgical options are used: bilateral neck exploration (BNE) and minimally invasive parathyroidectomy (MIP). While there are open, endoscopic, and video-assisted MIP (MIVAP) approaches, most often an open lateral MIP technique is used. In addition, endoscopic or robotic parathyroidectomy methods performed from remote regions outside the neck have been reported. Although currently MIP is the standard treatment option in selected patients with positive imaging, BNE remains the gold standard procedure in parathyroid surgery. In 80% to 90% of patients with pHPT, a pathological parathyroid gland can be detected with preoperative imaging methods and MIP can be applied. However, the pathological gland may not be found during a MIP procedure as a result of false positive results. The parathyroid surgeon must also know the BNE technique and be able to switch to BNE and change the surgical strategy if necessary. If the intended gland is not found in its normal anatomical site, possible embryological and acquired ectopic locations should be investigated. It should be kept in mind that MIP and BNE are not alternatives to each other, but rather complementary techniques for successful treatment in parathyroid surgery.
  • Publication
    Imaging Findings of the Unusual Presentations, Associations and Clinical Mimics of Acute Appendicitis
    (AVES, 2017) Demir, Mustafa Kemal; Savas, Yildiray; Furuncuoglu, Yavuz; Cevher, Tarik; Demiral, Serdar; Tabandeh, Babek; Aslan, Melisa; Bahcesehir University; Medical Park Hospitals Group; Istanbul Haseki Training & Research Hospital; Bahcesehir University; Medical Park Hospitals Group; Medical Park Hospitals Group; Bahcesehir University; Medical Park Hospitals Group; Bahcesehir University
    There are many kinds of unusual presentations or associations and clinical mimics of acute appendicitis, and definitive diagnosis requires knowledge of the imaging findings in some cases. The unusual presentations and associations of acute appendicitis included in this study are perforated appendicitis, acute appendicitis occurring in hernias, acute appendicitis with cystic endosalpingiosis, intussusception of appendix, and acute appendicitis with pregnancy. We also present uncommon gastrointestinal, urinary and gynecologic clinical mimics of acute appendicitis including anomalous congenital band, duplication cysts, giant Meckel's diverticulitis, inflammatory fibroid polyp, renal artery thrombosis, spontaneous urinary extravasation and OHVIRA syndrome. Familiarity with these entities may improve diagnostic accuracy and enable the quickest and most appropriate clinical management.
  • Publication
    Basic Principles and Standardization of Intraoperative Nerve Monitoring in Thyroid Surgery
    (KARE PUBL, 2017) Uludag, Mehmet; Aygun, Nurcihan; Kaya, Cemal; Tanal, Mert; Oba, Sibel; Isgor, Adnan; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; Siverek State Hospital; Istanbul Sisli Hamidiye Etfal Training & Research Hospital; Bahcesehir University
    Voice changes after thyroid surgery are frequent and one of the most important complications. Both the recurrent laryngeal nerve (RLN) and the external branch of the superior laryngeal nerve (EBSLN) must be preserved to minimize the patient's voice and respiratory problems after surgery. Intraoperative neuromonitoring (IONM) is a method based on dynamically evaluating motor function of the nerve during surgery in addition to the visual identification of the nerve. Intraoperative neuromonitoring was introduced 50 years ago in thyroid surgery and IONM via endotracheal tube with surface electrodes has become a standard applied method for reasons such as convenience, simplicity, non-invasiveness and safety, and nowadays is used in thyroid surgery. The use of IONM for RLN and EBSLN is increasing in thyroid surgery. Experience and standardization is essential for proper use of IONM for both anesthesiologist and surgeon. In this context, the learning curve for both surgeons and anesthetists is about 50-100 cases. Intraoperative neuromonitoring makes a significant contribution to the identification and functional evaluation of both RLN and EBSLN. RLN monitorisation can be performed intermittently with the monitoring probe or continuously with the aid of a probe applied to the vagus. Standardization of RLN monitoring includes the vocal cord examination via preoperative laryngoscopy (L1), getting signals from ipsilateral vagus prior to RLN dissection (V1), stimulation of RLN at the first point found in the tracheoesophageal groove (R1), stimulation of the RLN from the most proximal point it was revealed after the dissection was completed (R2), vagus stimulation after surgical site bleeding control is complete (V2), vocal cord examination via postoperative laryngoscopy (L2). V2 is the most appropriate test to predict postoperative vocal cord function. In the intermittent IONM of RLN, only the nerve stimulated by the probe and the point that the nerve is stimulated inform about the function of the distal part. Continuous IONM allows continuous follow-up of RLN function while dissecting the thyroid gland by continuous stimulation of the RLN with the probe applied to the vagus at the neck before RLN leaves the vagus. Primarily in EBSLN monitoring, the contraction of the cricothyroid muscle, which is located in the surgical field and whose motor neuron is EBSLN, is evaluated. Intraoperative neuromonitoring is a method that contributes to many aspects of thyroidectomy and increases the standards of thyroidectomy, together with significant contribution to the detection and functional evaluation of both RLN and EBSLN.
  • Publication
    What has changed about the eight edition of the differentiated thyroid carcinomas TNM classification system? How will it effect the clinical practice?
    (KARE PUBL, 2017) Uludag, Mehmet; Isgor, Adnan; University of Health Sciences Turkey; Bahcesehir University
    The eighth edition of the TNM classification system was announced. Thyroid cancers were included in the fourth edition of the TNM classification system which was published in 1987. Each version of the TNM system which is updated based on evidence in the literature, includes some important differences from the previous version for the differentiated thyroid carcinomas (DTCs), like other cancers. Seventeen different classification systems for thyroid cancer have been developed until today. Some of these systems are quite complex and are difficult to use in practice. It has been shown that the TNM system with the new regaulations is the most consistent and applicable staging system for DTC in different patient groups, and the TNM system is now the most commonly used classification system in thyroid cancer, as in other cancer types. The most important update of the eighth version is that the age as prognostic factor is regulated as younger and older than 55 years, which has been divided as younger/older than 45 years of age in prior editions. Furthermore, the change in the definition of T3 in the T stage is remarkable. In the seventh edition, the definition of minimally invasive extrathyroidal extension and the definition of perithyroidal soft tissue included in its example have been abolished. Macroscopic extension into any of the strap muscles was moved to the T3 category in the eighth edition. In N staging in the 7th edition, the upper mediastinal lymph node involvement which took place in N1b was moved to the N1a category. In the eighth edition, it is observed that generally in patients over 55 years old have a stage downgrade in all stages compared to the seventh edition. In the eighth edition, the appropriate tumor stage can easily be determined. In patients under the age of 55 years, patients with distant metastases were defined as stage II, and without as stage I. Patients with distant metastasis over the age of 55 years are defined as stage IVB. The stages of patients without distant metastases over the age of 55 years can be defined by other clinical features (intrathyroidal tumor, macroscopic extrathyroidal extension, lymph node metastasis and distant metastasis). If there is no lymph node metastasis in patients with intrathyroidal tumors smaller than 4 cm (T1, T2), it is called stage 1, and stage II, if lymph node metastasis is present. Patients with intrathyroidal tumors greater than 4 cm (T3) are placed in stage II, regardless of lymph node status (N0 or N1). In tumors with macroscopic extrathyroidal extension, irrespective of the lymph node metastasis, the tumor is in stage II if only invasive into the strap muscles, and stage III if extended to subcutaneous tissue, larynx, trachea, recurrent laryngeal nerve and esophagus, and stage IVA if extended to the prevertebral fascia, mediastinal vessels or if surrounded carotid artery. TNM classification is a staging system that reliably predicts disease-specific survival in the DTC. The eighth edition of TNM compared to the previous editions classifies a large proportion of patients with DTC in low-risk groups in terms of mortality, and initial evaluations show that it may be more suitable in predicting disease-specific survival.